CAS: 170277-31-3 - Immunoglobulin G, anti-(human tumor necrosis factor), (human-mouse monoclonal cA2 heavy chain), disulfide with human-mouse monoclonal cA2 light chain, dimer
Fórmula:Unspecified
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Infliximab CRS REF: 41-Y0002047CAS: 170277-31-3 | - - - | 115,00 € | Mar 21 Ene 25 |
 | Infliximab (10 mg/ml) REF: 3D-FI139130CAS: 170277-31-3 | Min. 95% | 474,00 €~2.039,00 € | Vie 31 Ene 25 |
 | Infliximab REF: TM-T9921CAS: 170277-31-3 | 98% - 99.70% | 95,00 €~1.208,00 € | Lun 10 Mar 25 |
Ref: 41-Y0002047
| 100mg | 115,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Infliximab (10 mg/ml)
CAS:170277-31-3
Infliximab is a chimeric monoclonal antibody against tumor necrosis factor-alpha (TNF-α). It binds to the …
Pureza:
Min. 95%
Forma y color:
Powder
Ref: 3D-FI139130
| 5mg | 474,00 € | ||
| 10mg | 663,00 € | ||
| 25mg | 902,00 € | ||
| 50mg | 1.358,00 € | ||
| 100mg | 2.039,00 € |
Entrega estimada en Estados Unidos, el Viernes 31 de Enero de 2025
Infliximab
CAS:170277-31-3
Infliximab is a chimeric monoclonal antibody that inhibits TNF-α. Infliximab can be used to treat …
Pureza:
98% - 99.70%
Forma y color:
Liquid
Peso molecular:
149 kDa
Ref: TM-T9921
| 1mg | 95,00 € | ||
| 2mg | 157,00 € | ||
| 5mg | 254,00 € | ||
| 25mg | 626,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
